Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2025-12-24 @ 7:50 PM
NCT ID:
NCT00530504
Eligibility Criteria:
Inclusion Criteria:
* 18 years and above
* Informed consent
* Intent to use the PROTÉGÉ™ GPS™ and PROTÉGÉ™ RX and SpiderFX™ to treat carotid artery disease per Instructions for Use
* Meet Instruction for Use (IFU)/ Centers for Medicare \& Medicaid Services (CMS)defined anatomical or clinical high risk criteria
Exclusion Criteria:
* Subjects with contraindications as outlined in the Instructions for Use
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00530504
Study Brief:
Protocol Section:
NCT00530504